Cargando…

ICOS/ICOSLG and PD-1 Co-Expression is Associated with the Progression of Colorectal Precancerous- Carcinoma Immune Microenvironment

PURPOSE: This study aimed to investigate the expression of inducible T-cell co-stimulator (ICOS) and its ligand (ICOSLG), along with their association with clinicopathological features and influence on the immune profile in colorectal cancer (CRC). PATIENTS AND METHODS: The Cancer Genome Atlas Color...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yu, Wang, Xue-Li, Liu, Jing-Jing, Qian, Zhen-Yuan, Pan, Zheng-Yang, Song, Ni-Ping, Chen, Hui-Yan, Zhang, Wei, Zhang, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008008/ https://www.ncbi.nlm.nih.gov/pubmed/36915615 http://dx.doi.org/10.2147/JIR.S401123

Ejemplares similares

Plasma IL-8 and ICOSLG as prognostic biomarkers in glioblastoma
por: Holst, Camilla Bjørnbak, et al.
Publicado: (2021)

The combination of novel immune checkpoints HHLA2 and ICOSLG: A new system to predict survival and immune features in esophageal squamous cell carcinoma
por: Zhang, Chaoqi, et al.
Publicado: (2020)

ICOSLG-associated immunological landscape and diagnostic value in oral squamous cell carcinoma: a prospective cohort study
por: Dong, Yuexin, et al.
Publicado: (2023)

The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemia
por: Külp, Marius, et al.
Publicado: (2022)

Unbalanced Expression of ICOS and PD-1 in Patients with Neuromyelitis Optica Spectrum Disorder
por: Xue, Qun, et al.
Publicado: (2019)

The clinical impact of ICOS signal in colorectal cancer patients
por: Zhang, Yan, et al.
Publicado: (2016)

The Immune Landscapes of Polypoid and Nonpolypoid Precancerous Colorectal Lesions
por: Maglietta, Antonella, et al.
Publicado: (2016)

Publisher Correction: Unbalanced Expression of ICOS and PD-1 in Patients with Neuromyelitis Optica Spectrum Disorder
por: Xue, Qun, et al.
Publicado: (2020)

Structural characterization of the ICOS/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies
por: Rujas, Edurne, et al.
Publicado: (2020)

ICO investors
por: Fahlenbrach, Rüdiger, et al.
Publicado: (2020)

CMTM6 and PD-L1 coexpression is associated with an active immune microenvironment and a favorable prognosis in colorectal cancer
por: Peng, Qi-Hua, et al.
Publicado: (2021)

Precancerous Lesions in Colorectal Cancer
por: Sandouk, Fayez, et al.
Publicado: (2013)

Transcriptome Sequencing Reveals Potential Roles of ICOS in Primary Sjögren’s Syndrome
por: Luo, Jing, et al.
Publicado: (2020)

Single‐cell transcriptomics provides insights into the origin and immune microenvironment of cervical precancerous lesions
por: Li, Chunbo, et al.
Publicado: (2023)

Colloque ICO '89
por: Moulin, B, et al.
Publicado: (1989)

Proteomic profiling identifies signatures associated with progression of precancerous gastric lesions and risk of early gastric cancer
por: Li, Xue, et al.
Publicado: (2021)

The rationale behind targeting the ICOS-ICOS ligand costimulatory pathway in cancer immunotherapy
por: Solinas, Cinzia, et al.
Publicado: (2020)

Role of endocytosis and trans‐endocytosis in ICOS costimulator‐induced downmodulation of the ICOS Ligand
por: Aragoneses‐Fenoll, Laura, et al.
Publicado: (2021)

Regulatory T cells, especially ICOS(+) FOXP3(+) regulatory T cells, are increased in the hepatocellular carcinoma microenvironment and predict reduced survival
por: Tu, Jian-Fei, et al.
Publicado: (2016)

Associations of ICOS and PD.1 Gene Variants with Colon Cancer Risk in The Iranian Population
por: Shamsdin, Seyedeh Azra, et al.
Publicado: (2018)

The ubiquitin ligase Peli1 inhibits ICOS and thereby Tfh-mediated immunity
por: Huang, Xinfang, et al.
Publicado: (2021)

ICOS(+) Tregs: A Functional Subset of Tregs in Immune Diseases
por: Li, Dan-Yang, et al.
Publicado: (2020)

ICOS, SLAM and PD-1 expression and regulation on T lymphocytes reflect the immune dysregulation in patients with HIV-related illness with pulmonary tuberculosis
por: Jurado, Javier Oscar, et al.
Publicado: (2012)

An “expressionistic” look at serrated precancerous colorectal lesions
por: Marra, Giancarlo
Publicado: (2021)

Overexpression of PD-1 on T cells promotes tolerance in cardiac transplantation via ICOS-dependent mechanisms
por: Borges, Thiago J., et al.
Publicado: (2021)

ICOS-deficient and ICOS YF mutant mice fail to control Toxoplasma gondii infection of the brain
por: O’Brien, Carleigh A., et al.
Publicado: (2020)

Identification and Validation of Plasma Metabolomic Signatures in Precancerous Gastric Lesions That Progress to Cancer
por: Huang, Sha, et al.
Publicado: (2021)

PD-1 and ICOS counter-regulate tissue resident regulatory T cell development and IL-10 production during flu
por: McGee, Michael C., et al.
Publicado: (2022)

ICOS DNA methylation regulates melanoma cell-intrinsic ICOS expression, is associated with melanoma differentiation, prognosis, and predicts response to immune checkpoint blockade
por: Ralser, Damian J., et al.
Publicado: (2023)

Sorafenib Alleviates Inflammatory Signaling of Tumor Microenvironment in Precancerous Lung Injuries
por: Cicek, Betul, et al.
Publicado: (2023)

Corrigendum: ICOS+ Tregs: A Functional Subset of Tregs in Immune Diseases
por: Li, Dan-Yang, et al.
Publicado: (2021)

PD-1 and ICOS coexpression identifies tumor-reactive CD4(+) T cells in human solid tumors
por: Duhen, Rebekka, et al.
Publicado: (2022)

Regulation of T follicular helper cells by ICOS
por: Hutloff, Andreas
Publicado: (2015)

ICOS regulates ILC2s in asthma
por: Maazi, Hadi, et al.
Publicado: (2015)

ICOS Co-Stimulation: Friend or Foe?
por: Wikenheiser, Daniel J., et al.
Publicado: (2016)

Microwave ablation induces Th1-type immune response with activation of ICOS pathway in early-stage breast cancer
por: Zhou, Wenbin, et al.
Publicado: (2021)

What Key Aspects Do ICOs Reveal About Their Businesses?
por: Laatikainen, Gabriella, et al.
Publicado: (2020)

Impact of mismatch-repair deficiency on the colorectal cancer immune microenvironment
por: Zhang, Yingyi, et al.
Publicado: (2017)

Gasdermin D in Different Subcellular Locations Predicts Diverse Progression, Immune Microenvironment and Prognosis in Colorectal Cancer
por: Wang, Jiahui, et al.
Publicado: (2021)

Pilot Study of Delayed ICOS/ICOS-L Blockade With αCD40 to Modulate Pathogenic Alloimmunity in a Primate Cardiac Allograft Model
por: O’Neill, Natalie A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r2dttpiain8j3ok0vk6vg2uvrq